#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>By report
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Interpretive Data: This test is performed pursuant to an agreement with Roche Molecular Systems, Inc. Test Information: Characteristics: Short stature with disproportionately short arms and legs, a large head, usually normal life span and intelligence; increased risk for death in infancy from compression of spinal cord and/or upper airway obstruction. Incidence: 1:25,000 Inheritance: Autosomal dominant; 80% arise from de novo mutations. Methods: PCR and fluorescent hybridization probes. Limitations: Mutations other than c.1138G>A and c.1138G>C will not be detected. Analytical Sensitivity and Specificity: Greater than 99% Clinical Sensitivity: Two mutations, c.1138G>A and c.1138G>C, in the FGFR3 gene account for greater than 99% of cases.
Please refer to Statement C in the Compliance Statements section in the front of the Laboratory Test Directory.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
83890 Isolation; 83898 Amplification; 83896 x2 Nucleic acid probes; 83912 Interpretation and report. FCC: 83900 Multiplex amplification; 83901 x14 Additional amplification; 83909 Capillary electrophoresis. MCC (0050608): 83890 Isolation; 83900 Amplification; 83901 x14 Amplification; 83909 Separation and identification; 83912 Interpretation and report.
|
*ExistCPT>
|